GL検索 v0.1.0
画像は 114 ページを描画したものです
page 114

p.114 抽出テキスト

profile and prognostic implications. J Am Coll Cardiol 2002; 40: 789- 795. PMID: 12204512 39. Melby SJ, Moon MR, Lindman BR, et al. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 2011; 141: 1424-1430. PMID: 21596173 40. Lancellotti P, Magne J, Donal E, et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 2012; 126: 851-859. PMID: 22832784 41. Luçon A, Oger E, Bedossa M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry. Circ Cardiovasc Interv 2014; 7: 240-247. PMID: 24569597 42. Barbieri A, Bursi F, Grigioni F, et al. ; Mitral Regurgitation International DAtabase (MIDA) Investigators. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011; 32: 751-759. PMID: 20829213 43. Ghoreishi M, Evans CF, DeFilippi CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 2011; 142: 1439-1452. PMID: 21962906 44. Miller WL, Mahoney DW, Enriquez-Sarano M. Quantitative Doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: independent effect of pulmonary hypertension. Circ Cardiovasc Imaging 2014; 7: 330-336. PMID: 24488981 45. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713. PMID: 20620859 46. Pellikka PA, Nagueh SF, Elhendy AA, et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 2007; 20: 1021-1041. PMID: 17765820 47. Sicari R, Nihoyannopoulos P, Evangelista A, et al. ; European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008; 9: 415-437. PMID: 18579481 48. Lancellotti P, Pellikka PA, Budts W, et al. The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017; 30: 101-138. PMID: 28164802 49. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005; 26: 1309-1313. PMID: 15820999 50. Lancellotti P, Lebois F, Simon M, et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005; 112 Suppl: I377-I382. PMID: 16159850 51. Otto CM, Pearlman AS, Kraft CD, et al. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol 1992; 20: 1160- 1167. PMID: 1401617 52. Rafique AM, Biner S, Ray I, et al. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am J Cardiol 2009; 104: 972-977. PMID: 19766766 53. Magne J, Lancellotti P, Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010; 122: 33-41. PMID: 20566950 54. Aviles RJ, Nishimura RA, Pellikka PA, et al. Utility of stress Doppler echocardiography in patients undergoing percutaneous mitral balloon valvotomy. J Am Soc Echocardiogr 2001; 14: 676-681. PMID: 11447412 55. Garbi M, Chambers J, Vannan MA, et al. Valve Stress Echocardiography: A Practical Guide for Referral, Procedure, Reporting, and Clinical Implementation of Results From the HAVEC Group. JACC Cardiovasc Imaging 2015; 8: 724-736. PMID: 26068289 56. Picano E, Pibarot P, Lancellotti P, et al. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol 2009; 54: 2251-2260. PMID: 19958961 57. Lin SS, Roger VL, Pascoe R, et al. Dobutamine stress Doppler hemodynamics in patients with aortic stenosis: feasibility, safety, and surgical correlations. Am Heart J 1998; 136: 1010-1016. PMID: 9842014 58. Clavel MA, Magne J, Pibarot P. Low-gradient aortic stenosis. Eur Heart J 2016; 37: 2645-2657. PMID: 27190103 59. Monin JL, Quéré JP, Monchi M, et al. Low-gradient aortic stenosis:

operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003; 108: 319-324. PMID: 12835219 60. Levy F, Laurent M, Monin JL, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 2008; 51: 1466-1472. PMID: 18402902 61. Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005; 26: 1528-1532. PMID: 15814566 62. Messika-Zeitoun D, Johnson BD, Nkomo V, et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 2006; 47: 2521-2527. PMID: 16781383 63. Bertrand PB, Schwammenthal E, Levine RA, et al. Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications. Circulation 2017; 135: 297-314. PMID: 28093494 64. Chan KM, Punjabi PP, Flather M, et al. RIME Investigators. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 2012; 126: 2502-2510. PMID: 23136163 65. Clavel MA, Messika-Zeitoun D, Pibarot P, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol 2013; 62: 2329-2338. PMID: 24076528 66. Hayashida K, Bouvier E, Lefèvre T, et al. Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation. EuroIntervention 2012; 8: 546-555. PMID: 22995080 67. Jilaihawi H, Doctor N, Kashif M, et al. Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol 2013; 61: 908- 916. PMID: 23449425 68. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation: new criteria to predict vascular complications. JACC Cardiovasc Interv 2011; 4: 851-858. PMID: 21851897 69. Opolski MP, Staruch AD, Jakubczyk M, et al. CT Angiography for the Detection of Coronary Artery Stenoses in Patients Referred for Cardiac Valve Surgery: Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging 2016; 9: 1059-1070. PMID: 27344418 70. Hayashida K, Bouvier E, Lefèvre T, et al. Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis. Circ Cardiovasc Interv 2013; 6: 284-291. PMID: 23756698 71. Makkar RR, Fontana G, Jilaihawi H, et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med 2015; 373: 2015-2024. PMID: 26436963 72. Chakravarty T, Søndergaard L, Friedman J, et al. ; RESOLVE, SA- VORY Investigators. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet 2017; 389: 2383-2392. PMID: 28330690 73. Yanagisawa R, Tanaka M, Yashima F, et al. Early and Late Leaflet Thrombosis After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv 2019; 12: e007349. PMID: 30732472 74. Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 2006; 8: 503-507. PMID: 16755839 75. Cawley PJ, Hamilton-Craig C, Owens DS, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging 2013; 6: 48-57. PMID: 23212272 76. Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NAS- CI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010; 55: 2614-2662. PMID: 20513610 77. 高本眞一,本村昇,宮田裕章,他.本邦における2013,2014年

の心臓血管外科手術の現状:日本心臓血管外科手術データベース(JCVSD)からの報告.JCVSD の理念と歴史.日本心臓血管外科学会雑誌 2017; 46: 187-190. 78. 日本心臓血管外科手術データベース.Japan SCORE.https://jcvsd. org/JapanSCORE/ 79. EuroSCORE Study Group. EuroSCORE II. http://euroscore.org/calc. html 80. The Society of Thoracic Surgeons (STS). Online STS Adult Cardiac